HbA1c (Whole Blood)

Diabetes

Report in 4Hrs

At Home

No Fasting Required

Details

Measures average blood glucose over the past 2–3 months; essential for diabetes diagnosis and monitoring.

₹99₹495

82% OFF

HbA1c (Whole Blood) - Comprehensive Medical Test Information Guide

Why is it done?
- Test Measurement: Measures the percentage of glycated hemoglobin in whole blood, reflecting average blood glucose levels over the past 2-3 months
- Diagnostic Purpose: Screen for and diagnose type 2 diabetes, prediabetes, and gestational diabetes
- Monitoring Purpose: Monitor long-term glycemic control in patients with diabetes undergoing treatment
- Risk Assessment: Assess cardiovascular and renal disease risk in patients with known diabetes
- Primary Indications: Routine screening in adults age 45+, patients with symptoms of diabetes, individuals with risk factors (obesity, family history, sedentary lifestyle), and follow-up monitoring every 3-6 months for diabetic patients
Normal Range
- Reference Ranges: Normal: <5.7% | Prediabetes: 5.7% - 6.4% | Diabetes: ≥6.5%
- Units of Measurement: Percentage (%) or Equivalent mmol/mol conversion (Normal: <39 mmol/mol | Prediabetes: 39-46 mmol/mol | Diabetes: ≥48 mmol/mol)
- Normal Result Interpretation: <5.7% indicates normal glucose metabolism and low risk for diabetes development; suggests good overall glucose control in non-diabetic individuals
- Borderline Result Interpretation: 5.7% - 6.4% indicates prediabetes; increased risk of developing type 2 diabetes without lifestyle modifications
- Abnormal Result Interpretation: ≥6.5% indicates diabetes diagnosis; requires confirmation with repeat testing or additional glucose studies
- High Result Significance: Elevated levels (>7%) indicate inadequate glucose control and increased risk of diabetic complications including neuropathy, nephropathy, and retinopathy
Interpretation
- Result Value Analysis: HbA1c <5.7% = excellent glucose control; 5.7-6.4% = prediabetic range requiring intervention; ≥6.5% = diabetes diagnosis; >8% = poor control requiring treatment intensification
- Diagnostic Criteria: Two consecutive HbA1c measurements ≥6.5% or single ≥6.5% with symptoms confirm diabetes diagnosis per American Diabetes Association guidelines
- Treatment Goals: Generally <7% for most diabetic patients; <6.5% for newly diagnosed; <8% for elderly or high-risk patients; individualized targets based on comorbidities and hypoglycemia risk
- Clinical Significance Patterns: Rising HbA1c indicates worsening control; stable levels suggest adequate therapy; decreasing levels indicate successful intervention and reduced complication risk
- Factors Affecting Results: Hemoglobinopathies (sickle cell, thalassemia) may falsely elevate or lower results; chronic kidney disease shortens RBC lifespan affecting accuracy; iron deficiency anemia may increase values; recent transfusions affect measurements; pregnancy and certain medications can influence results
- Clinical Correlation: Discordance between HbA1c and fasting glucose may indicate postprandial hyperglycemia or variable glycemic patterns; always correlate with symptomatology and fasting glucose for complete clinical picture
Associated Organs
- Primary Organ System: Endocrine system, specifically pancreatic islet cells (beta cells) responsible for insulin production and glucose regulation
- Commonly Associated Conditions: Type 2 diabetes mellitus, type 1 diabetes, prediabetes, gestational diabetes mellitus, metabolic syndrome, obesity, polycystic ovary syndrome (PCOS)
- Diagnostic Purpose Diseases: Helps diagnose diabetes and prediabetes; monitors treatment efficacy; identifies patients at risk for hyperglycemic emergencies
- Organ-Specific Complications: Kidneys: diabetic nephropathy, chronic kidney disease; Eyes: diabetic retinopathy, cataracts; Nervous System: peripheral neuropathy, autonomic dysfunction; Heart/Blood Vessels: coronary artery disease, atherosclerosis, hypertension; Feet: neuropathic ulcers, amputation risk
- Vascular Complications: Elevated HbA1c significantly increases risk of myocardial infarction, stroke, and peripheral vascular disease; each 1% increase in HbA1c increases cardiovascular mortality risk approximately 15-20%
- Metabolic Syndrome Association: Abnormal HbA1c often occurs with dyslipidemia and hypertension, creating compounded cardiovascular risk requiring comprehensive management
Follow-up Tests
- Initial Diagnostic Confirmation: Fasting blood glucose, random blood glucose, or oral glucose tolerance test (OGTT); repeat HbA1c testing for confirmatory diagnosis
- Glycemic Monitoring Tests: Home blood glucose monitoring, continuous glucose monitoring (CGM), fructosamine levels for 2-3 week glucose trends
- Complication Screening: Urine microalbumin/protein (renal); serum creatinine and eGFR (kidney function); dilated retinal examination (retinopathy); comprehensive metabolic panel; lipid panel
- Cardiovascular Risk Assessment: Lipid panel, blood pressure monitoring, EKG or stress testing if indicated, carotid ultrasound, ankle-brachial index for vascular disease
- Monitoring Frequency: Newly diagnosed or poorly controlled: every 3 months; stable control: every 6 months; excellent control on stable therapy: annually; at goal: every 6-12 months
- Related Complementary Tests: C-peptide (beta cell function), insulin level (assess insulin resistance), autoimmune markers for type 1 diabetes discrimination, liver enzymes before metformin initiation
- Annual Screening Tests: Comprehensive metabolic panel, liver function tests, lipid panel, urine protein/microalbumin, thyroid function (TSH), foot examination for neuropathy and ulcers
Fasting Required?
- Fasting Requirement: NO - Fasting is NOT required for HbA1c testing. The test measures glucose attached to hemoglobin over 2-3 months and is not affected by recent food intake
- Timing Independence: Test can be performed at any time of day without regard to meals; results are unaffected by meal timing, food type, or recent glucose intake
- Medication Considerations: Continue all regular medications including diabetes medications, blood pressure medications, and other chronic disease treatments; no medication adjustment or withholding needed
- Patient Preparation: No special preparation required; may eat and drink normally; maintain usual daily activities; arrive for appointment with arm accessible for blood draw
- Special Instructions: Inform laboratory of hemoglobin variants or blood disorders that may affect results; note recent transfusions (within 3 months) as these may impact accuracy; report all current medications to healthcare provider
- Sample Collection: Simple capillary or venous whole blood draw; requires only small blood sample; can be performed in clinical laboratory, point-of-care setting, or home testing kit

How our test process works!